key: cord-0965488-bxh64ira authors: Piga, Matteo; Floris, Alberto; Congia, Mattia; Chessa, Elisabetta; Cangemi, Ignazio; Cauli, Alberto title: Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic date: 2021-08-05 journal: Rheumatology (Oxford) DOI: 10.1093/rheumatology/keab632 sha: 9f3117dc5c4e4397a9f598287fbc25324e4d7649 doc_id: 965488 cord_uid: bxh64ira OBJECTIVE: To evaluate the reliability of virtual video-assisted visits, added to the tight control strategy for inflammatory rheumatic diseases (IRDs), in identifying patients that need treatment adjustment. METHODS: Tightly followed-up adult patients with rheumatoid arthritis, psoriatic arthritis (PsA), ankylosing spondylitis, and systemic lupus erythematosus (SLE) performed a video consultation during COVID19 lockdown and repeated the same rheumatology evaluations through a face-to-face visit within 2-weeks. Sensitivity and specificity of virtual visits for treatment decisions (categorized as unchanged, adjusted/escalate, tapered/discontinued, need for further examinations), and the intraclass correlation coefficient (ICC) for virtually measured disease activity and patient-reported outcomes (PROs) were calculated with 95% confidence interval (95%CI) using face-to-face visits as the reference method. RESULTS: In 89 out of 106 (84.0%) patients, face-to-face visits confirmed the remotely delivered treatment decision. Video-visiting showed excellent sensitivity (94.1% with 95%CI 71.3%-99.9%) and specificity (96.7%; 95%CI 90.8% to 99.3%) in identifying the need for treatment adjustment due to inadequate disease control. The major driver for the low sensitivity of virtual video consultation (55.6%; 95%CI 21.2%-86.3%) in identifying the need for treatment tapering was SLE diagnosis (OR 10.0; 95%CI 3.1-32.3; p < 0.001), mostly because of discordance with face-to-face consultation in glucocorticoid tapering. Remotely evaluated PROs showed high reliability (ICC range 0.80 to 0.95) whilst disease activity measures had less consistent data (ICC range 0.50 to 0.95), especially those requiring more extensive physical examination such as in SLE and PsA. CONCLUSION: Video-visiting proved high reliability in identifying the need for treatment adjustment and might support the IRDs standard tight-control strategy. INTRODUCTION Tightly monitoring and adjusting treatment according to disease activity, safety concerns, and comorbidities, in a shared decision-making process, is pivotal to improve outcomes of inflammatory rheumatic diseases (IRDs) [1] [2] [3] [4] . Face-to-face consultation represents the standard approach in rheumatology, but telemedicine applications have gained a growing role in the past years and boomed during COVID-19 pandemics allowing rheumatologists to continue caring for patients remotely [5, 6] . However, virtual video-assisted visits are still far from widespread, their application to rheumatology has been only addressed by a small number of studies, and researches into their reliability compared with in-person visits are lacking [6] . Two recent systemic literature reviews independently came to the same conclusion that not enough outcomes information was available about the effectiveness of virtual visits for IRDs [7, 8] . The present study aimed to evaluate the reliability of virtual video-assisted follow-up visits in detecting the need for adjusting treatment due to inadequate disease control in patients affected by IRDs routinely followed up in a tight-control clinical setting. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 During the first SARS-Cov2 Italian outbreak, from 9 March 2020 to 9 June 2020 our tertiary referral outpatient rheumatology clinic was converted into a telemedicine service due to the lockdown imposed in an attempt to halt the viral spreading. Adult patients, routinely followed up in our tight-control clinics for rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and systemic lupus erythematosus (SLE), who consecutively performed a virtual video-assisted consultation during the last 2 weeks of lockdown prospectively completed the rheumatology evaluation through a face-to-face visit within 2 weeks. Four consultant rheumatologists (AF, MC, EC, IC) delivered both the virtual consultations (no previous experience) and the face-to-face visits to the same patients already entrusted to their care. The Ethics Committee of the Azienda Ospedaliero Universitaria of Cagliari approved the present study (protocol n. 8557), and all patients provided written informed consent to participate. The remotely delivered consultations were performed using a freely available web-based video-conferencing platform supported by smartphone and desktop. Demographic details, disease activity measures, patient-reported outcomes (PROs), laboratory results, and ongoing medications were collected during the video-assisted and face-to-face consultations (Table 1) . During video-visiting, patients were coached by physicians through selfassessment of swollen (SJC) and tender joint counts (TJC) applying a prespecified standardized procedure to increase reliability [9] . Patients were instructed on what is inflamed SJs and TJs and how to assess them for detecting softness, elasticity, and pain; afterward, they were asked to show their joints on video and perform a physician-driven examination of them reporting if joints were painful, Page 5 of 23 Rheumatology 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 swollen, or tender. Treatment decision at the end of the visits was categorized in four classes: i) unchanged (i.e. enough information collected to make a decision; continue with the same treatment); ii) adjusted treatment for inadequate disease control (i.e. enough information; new prescription or increasing dosage of any DMARDs, glucocorticoids or NSAIDs -the latter only for PsA and AS); iii) treatment tapering/cessation for persistently adequate disease control (i.e. enough information; increase time-intervals administration, reduce the dosage or discontinue any DMARDs or glucocorticoids); iv) need further examinations (i.e. no enough information; require a physical examination, new blood exams or imaging to better assess disease activity or safety issue -excluding screening for biologics). Adverse events were also recorded. The sensitivity and specificity of virtual consultations in identifying the need for adjusting treatment due to inadequate disease activity control was the primary outcome of the study, whereas other treatment decisions were secondary outcomes. Patients were not involved in the audit planning and design but were asked to assess the impact and satisfaction with the remotely delivered consultations by completing an anonymous, self-administered, web-based, 5-point Likert scale questionnaire. The sensitivity and specificity of virtual consultations were calculated using face-to-face visits as the reference method. A forward logistic regression model was built to identify factors independently associated with a modification of the remotely delivered treatment decision during the face-to-face consultation. Age, gender, education level, working status, diagnosis, disease duration, ongoing treatment, treatment duration, prednisone use, and examining physician were included in the model. The odds ratio (OR) with 95% confidence interval was calculated. P-value <0.05 was considered significant. The intraclass correlation coefficient (ICC) single measure was used in subgroup analysis for each iRDs to assess the reliability (ICC < 0.5 poor, 0.5-0.75 moderate, 0.75-0.90 good, > 0.90 excellent) of disease activity measures and PROs performed during video-visiting and face-to-face consultations. Overall, 106 (25 RA, 30 PsA, 22 AS, 29 SLE) out of 120 patients who performed a virtual videoassisted consultation between 25 May and 9 June 2020, agreed to participate. Demographics and treatment information are reported in Table 2 . The high prevalence of patients treated with biologic and targeted synthetic DMARDs, and with prednisone in the case of SLE, is related to their referral to our tertiary level tight-control clinics, which collects those patients that need frequent monitoring for active disease, evaluating the response to treatment changes or supervising steroid-tapering. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 control using face-to-face visits as the gold standard (Supplementary Disease activity measures showed heterogeneous results in terms of the agreement between virtual and face-to-face consultations, ranging from moderate to excellent reliability ( Table 4 ). PROs measured at the time of virtual visits and face-to-face consultations showed good to excellent agreement ( Table 4) . Overall, 101 patients answered the questionnaire reporting a high level of satisfaction with the telemedicine service, the virtual consultation, and the established patient-doctor relationship ( Figure 2 ). 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 have shown moderate sensitivity in identifying those patients eligible for tapering of daily prednisone dose. Considering the impact of prednisone on damage accrual [14] , the extent to which video-visiting can be implemented in patients with SLE under tight monitoring will have to be further investigated in larger studies. This study has some limitations. The major one is that both virtual and face-to-face visits were performed by the same observer, which could have led to a potential confirmation bias and suggests caution in interpreting study results. However, changing the observer between visits would have introduced an additional confounding factor (i.e. inter-observer reliability) and hampered the direct comparison between video-assisted and face-to-face visits Therefore, more than one physician was enrolled as an independent observer trying to minimize the potential effect of the confirmation bias by accordingly adjusting the regression model. The small IRDs subgroups prevented an in-depth diseasespecific analysis, which is another study limitation. In conclusion, video-visiting should not replace the standard approach but might be effectively used in supports of the tight-control strategy to increase the number of consultations reducing out-patient visits, and identifying the need for adjusting treatment in routinely followed up patients affected with IRDs. Although our findings cannot be generalized to different contexts, and especially to first visits, this evidence could be extremely useful in setting up tele-rheumatology clinics during COVID19 outbreaks, when local measures of social distancing are in effect, or even beyond pandemics in case a patient cannot attend the face-to-face visit or whenever the capacity of rheumatology services is severely reduced. Page 10 of 23 Rheumatology 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article. The data underlying this article will be shared at reasonable request to the corresponding author. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Table 2 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 Table 4 . Agreement between remotely delivered and face-to-face consultations in scoring disease activity indices and patient-reported outcomes. sTJC: self-assessed tender joint count. sSJC: self-assessed swollen joint count. DAS28: Disease activity score 28. PhGA: physician global assessment (0-10). RAID: rheumatoid arthritis impact of disease. PtGA: patient global assessment (0-10). 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Page 20 of 23 Rheumatology 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries Digital health technologies: opportunities and challenges in rheumatology Telerheumatology: a systematic review Telemedicine for patients with rheumatic diseases: Systematic review and proposal for research agenda Codevelopment of Patient Self-Examination Methods and Joint Count Reporting for Rheumatoid Arthritis EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 Telemedicine in rheumatology: a reliable approach beyond the pandemic Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort